| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000255857.1 |
ABT-263 (navitoclax) |
Sarcoma |
0.028859916 |
Resistant |
| ENSG00000255857.1 |
ABT-263 (navitoclax) |
Esophageal cancer |
0.022369586 |
Sensitive |
| ENSG00000255857.1 |
ABT-263 (navitoclax) |
Pancreatic adenocarcinoma |
0.023935265 |
Sensitive |
